VETOP logo

Vetoquinol BATS-CHIXE:VETOP Stock Report

Last Price

€100.60

Market Cap

€1.2b

7D

0%

1Y

n/a

Updated

11 May, 2024

Data

Company Financials +

VETOP Stock Overview

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. More details

VETOP fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance5/6
Financial Health5/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Vetoquinol SA Competitors

Price History & Performance

Summary of share price highs, lows and changes for Vetoquinol
Historical stock prices
Current Share Price€100.60
52 Week High€100.60
52 Week Low€100.60
Beta0.91
1 Month Change0%
3 Month Change-0.79%
1 Year Changen/a
3 Year Changen/a
5 Year Change86.99%
Change since IPO285.81%

Recent News & Updates

Recent updates

Shareholder Returns

VETOPGB PharmaceuticalsGB Market
7D0%3.9%1.0%
1Yn/a11.5%12.1%

Return vs Industry: Insufficient data to determine how VETOP performed against the UK Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how VETOP performed against the UK Market.

Price Volatility

Is VETOP's price volatile compared to industry and market?
VETOP volatility
VETOP Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement7.5%
Market Average Movement4.8%
10% most volatile stocks in GB Market10.7%
10% least volatile stocks in GB Market2.7%

Stable Share Price: VETOP has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine VETOP's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19332,497Matthieu Frechinwww.vetoquinol.com

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France.

Vetoquinol SA Fundamentals Summary

How do Vetoquinol's earnings and revenue compare to its market cap?
VETOP fundamental statistics
Market cap€1.16b
Earnings (TTM)€55.60m
Revenue (TTM)€529.30m

20.9x

P/E Ratio

2.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VETOP income statement (TTM)
Revenue€529.30m
Cost of Revenue€0
Gross Profit€529.30m
Other Expenses€473.70m
Earnings€55.60m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Sep 12, 2024

Earnings per share (EPS)4.70
Gross Margin100.00%
Net Profit Margin10.50%
Debt/Equity Ratio3.1%

How did VETOP perform over the long term?

See historical performance and comparison

Dividends

0.9%

Current Dividend Yield

16%

Payout Ratio

Does VETOP pay a reliable dividends?

See VETOP dividend history and benchmarks
When do you need to buy VETOP by to receive an upcoming dividend?
Vetoquinol dividend dates
Ex Dividend DateJun 04 2024
Dividend Pay DateJun 06 2024
Days until Ex dividend249 days
Days until Dividend pay date247 days

Does VETOP pay a reliable dividends?

See VETOP dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/05/11 00:37
End of Day Share Price 2024/02/12 00:00
Earnings2023/12/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vetoquinol SA is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Carole RozenCA Cheuvreux
Arnaud CadartCIC Market Solutions (ESN)
Alexandre LetzGilbert Dupont